Key facts
- This page summarizes Lale White's Form 4 filing for Cardiff Oncology, Inc. (CRDF).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jul 2022, 16:10.
Lale White - 05 Jul 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)
- Reporting relationship
- Director
- Issuer ticker
- CRDF
- Reported as of
- 05 Jul 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jul 2022, 16:10:40 UTC
- Prior SEC filing
- 10 Mar 2022
- Next SEC filing
- 20 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lale White
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Lale White filed Form 4 for Cardiff Oncology, Inc. (CRDF) on 06 Jul 2022.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRDF
transaction
Common Stock
Options Exercise
- Transaction value
- $75,031
- Shares
- +28,858
- Change %
- +41%
- Price
- $2.60
- Shares after
- 98,788
- Date
- 05 Jul 2022
- Ownership
- Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRDF
transaction
Derivative
Stock Options
Options Exercise
- Transaction value
- $75,031
- Shares
- -28,858
- Change %
- -32%
- Price
- $2.60
- Shares after
- 60,716
- Date
- 05 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,858
- Exercise price
- $2.60
* marks a reported price that did not pass the local price check.